• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Aditxt Inc (NQ: ADTX )

    0.2263 -0.0427 (-15.87%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,701,439
    Open 0.2600
    Bid (Size) 0.2253 (7)
    Ask (Size) 0.2276 (5)
    Prev. Close 0.2690
    Today's Range 0.2194 - 0.2640
    52wk Range 0.2574 - 24.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Acquisition Target Files Preliminary Proxy Seeking Stockholder Approval
    Via Investor Brand Network
    Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt
    From Aditxt, Inc.
    Via Business Wire

    Performance

    YTD
    -95.29%
    -95.29%
    1 Month
    -71.45%
    -71.45%
    3 Month
    -83.95%
    -83.95%
    6 Month
    -92.87%
    -92.87%
    1 Year
    -98.52%
    -98.52%

    More News

    Read More
    Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    ADTX Stock Earnings: Aditxt Reported Results for Q2 2024
    Via InvestorPlace
    Looking Into Aditxt's Recent Short Interest
    Via Benzinga
    InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Subsidiary Signs Agreement with Evofem Biosciences Inc. (OTCQB: EVFM) Involving Unique Endometriosis Diagnostic Test
    Via Investor Brand Network
    Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025
    From Aditxt, Inc.
    Via Business Wire
    BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX) Enters into Second Amendment to Amended and Restated Merger Agreement with Evofem
    Via Investor Brand Network
    Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024
    From Aditxt, Inc.
    Via Business Wire
    InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Seeks Grant Funding to Advance Early Detection, Management of Prostate Cancer
    Via Investor Brand Network
    Aditxt Subsidiary Pearsanta Submits a Grant Application Seeking to Advance Clinical Trials for Mitomic® Prostate Test, Targeting Early Detection in High-Risk Patients
    From Aditxt, Inc.
    Via Business Wire
    InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Announces Participation at H.C. Wainwright 26th Annual Global Investment Conference
    Via Investor Brand Network
    Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024
    From Aditxt, Inc.
    Via Business Wire
    BioMedNewsBreaks — Evofem Biosciences Inc. (EVFM) Subsidiary Appoints Industry Veteran as Subsidiary President
    Via Investor Brand Network
    Aditxt’s Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™)
    From Aditxt, Inc.
    Via Business Wire
    TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX), Appili Therapeutics (TSX: APLI) (OTC: APLIF) Enter Third Amending Agreement
    Via Investor Brand Network
    Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics
    From Aditxt, Inc.
    Via Business Wire
    BioMedNewsBreaks — Evofem Biosciences Inc. (EVFM) Releases Second-Quarter 2024 Financial Results, Company Update
    Via Investor Brand Network
    BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX) Releases Report on Annual Shareholders’ Meeting Activity
    Via Investor Brand Network
    Aditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders’ Meeting, Setting the Stage for 2024 and 2025 Strategic Plans
    From Aditxt, Inc.
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Aditxt Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
    From Aditxt, Inc.
    Via Business Wire
    TechMediaBreaks – Aditxt Inc. (NASDAQ: ADTX) Enters into $1.2M Registered Direct Offering Agreement
    Via Investor Brand Network
    Aditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
    From Aditxt, Inc.
    Via Business Wire
    TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Submits Proposal to CDMRP for Ovarian Cancer Detection Research Award
    Via Investor Brand Network
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.